Target Name: CCDC93
NCBI ID: G54520
Review Report on CCDC93 Target / Biomarker Content of Review Report on CCDC93 Target / Biomarker
CCDC93
Other Name(s): Coiled-coil domain-containing protein 93 | coiled-coil domain containing 93 | CCD93_HUMAN | Coiled-coil domain containing 93

CCDC93: A Drug Target / Disease Biomarker

CCDC93 is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell division and has been implicated in the development and progression of many diseases. In recent years, researchers have been interested in studying CCDC93 as a potential drug target or biomarker.

The CCDC93 gene is located on chromosome 6 and encodes a protein that is composed of 215 amino acids. The protein has several important functions. It is involved in the regulation of cell division and in the development of tissues such as the brain and nervous system. It is also involved in the regulation of cell growth and in the development of cancer.

One of the key functions of CCDC93 is its role in cell division. CCDC93 is a transcription factor that regulates the activity of genes that are involved in cell division. It helps to ensure that cells divide in a controlled and orderly manner and that each cell receives an accurate copy of the genetic information that it needs to function properly.

In addition to its role in cell division, CCDC93 is also involved in the regulation of cell growth. It helps to ensure that cells grow at a moderate rate and that they do not grow too quickly or too slowly. This is important for the development and maintenance of tissues such as the brain and nervous system.

CDC93 is also involved in the regulation of cell death. It helps to ensure that cells die at the appropriate time and that they do not undergo unnecessary cell division. This is important for the maintenance of tissue homeostasis and for the prevention of cancer.

In addition to its role in cell division, CCDC93 is also involved in the regulation of gene expression. It helps to ensure that the instructions in the genetic code are accurately copied and translated into proteins. This is important for the development and maintenance of tissues and for the regulation of many biological processes.

CDC93 is also involved in the regulation of cellular signaling. It helps to ensure that cells receive and respond to signals from other cells in the body. This is important for the development and maintenance of tissues and for the regulation of many biological processes.

In conclusion, CCDC93 is a protein that plays important roles in the regulation of cell division, cell growth, cell death, gene expression, and cellular signaling. As a result, it is a potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand the functions of CCDC93 and to develop effective treatments for the prevention and treatment of a variety of diseases.

Protein Name: Coiled-coil Domain Containing 93

Functions: Component of the CCC complex, which is involved in the regulation of endosomal recycling of surface proteins, including integrins, signaling receptor and channels. The CCC complex associates with SNX17, retriever and WASH complexes to prevent lysosomal degradation and promote cell surface recycling of numerous cargos such as integrins ITGA5:ITGB1 (PubMed:28892079, PubMed:25355947). Involved in copper-dependent ATP7A trafficking between the trans-Golgi network and vesicles in the cell periphery; the function is proposed to depend on its association within the CCC complex and cooperation with the WASH complex on early endosomes and is dependent on its interaction with WASHC2C (PubMed:25355947)

The "CCDC93 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC93 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCDC96 | CCDC97 | CCDC9B | CCDST | CCEPR | CCER1 | CCER2 | CCHCR1 | CCIN | CCK | CCK receptor | CCKAR | CCKBR | CCL1 | CCL11 | CCL13 | CCL14 | CCL15 | CCL15-CCL14 | CCL16 | CCL17 | CCL18 | CCL19 | CCL2 | CCL20 | CCL21 | CCL22 | CCL23 | CCL24 | CCL25 | CCL26 | CCL27 | CCL28 | CCL3 | CCL3-AS1 | CCL3L1 | CCL3L3 | CCL3P1 | CCL4 | CCL4L1 | CCL4L2 | CCL5 | CCL7 | CCL8 | CCM2 | CCM2L | CCN1 | CCN2 | CCN3 | CCN4 | CCN5 | CCN6 | CCNA1 | CCNA2 | CCNB1 | CCNB1IP1 | CCNB2 | CCNB2P1 | CCNB3 | CCNC | CCND1 | CCND2 | CCND2-AS1 | CCND3 | CCNDBP1 | CCNE1 | CCNE2 | CCNF | CCNG1 | CCNG2 | CCNH | CCNI | CCNI2 | CCNJ | CCNJL | CCNK | CCNL1 | CCNL2 | CCNO | CCNP | CCNQ | CCNQP1 | CCNT1 | CCNT2 | CCNT2-AS1 | CCNT2P1 | CCNY | CCNYL1 | CCNYL2 | CCP110 | CCPG1 | CCR1 | CCR10 | CCR12P | CCR2 | CCR3 | CCR4 | CCR4-NOT transcription complex | CCR5 | CCR5AS